Page 1 of 23

DR9.1 | Leprosy Epidemiology Classification and Clinical Features — SDL Guide

Learning Objectives

• Describe the global and Indian epidemiology of leprosy and the goals of the National Leprosy Eradication Programme (NLEP)
• Identify the three cardinal signs used by WHO to diagnose leprosy
• Describe the Ridley-Jopling immunological spectrum (TT, BT, BB, BL, LL, Indeterminate) by clinical, bacteriological, and histological features
• Apply the WHO operational classification (paucibacillary vs multibacillary) and explain how it differs from the Ridley-Jopling spectrum and why it guides multidrug therapy

INSTRUCTIONS

Leprosy remains a disease of major public-health and personal consequence in India, which still reports the largest number of new cases of any country in the world. A clinician who recognises the disease early, classifies it correctly, and starts the right treatment can prevent the nerve damage, deformity, and lifelong stigma that follow late diagnosis. This module builds the diagnostic foundation for the rest of the leprosy cluster: it teaches you to recognise the disease at the bedside, to place a patient on the Ridley-Jopling immunological spectrum, and — separately — to assign the WHO operational class that determines which multidrug-therapy regimen the patient receives. Keeping these two classification systems distinct is the single most important conceptual skill in leprosy care.

References

• Neena Khanna. Illustrated Synopsis of Dermatology and Sexually Transmitted Diseases, 5th ed. Ch: Leprosy (textbook)
• IADVL Textbook of Dermatology, 4th ed. Section: Leprosy — Classification and Clinical Features (textbook)
• National Leprosy Eradication Programme (NLEP) Operational Guidelines, Government of India; WHO Guidelines for the Diagnosis, Treatment and Prevention of Leprosy 2018 (guideline)

---

Version 2.0 | NMC CBME 2024

Recognising Leprosy — Morphology and Cardinal Signs

Recognising Leprosy: Cardinal Signs and Morphology

Leprosy presents to the clinician primarily through the skin and the peripheral nerves, and the diagnosis is fundamentally clinical. The World Health Organization defines three cardinal signs, and the presence of any ONE of them establishes the diagnosis of leprosy: (1) a hypopigmented or reddish skin patch with definite loss of sensation; (2) a thickened or enlarged peripheral nerve, with or without tenderness; and (3) a positive slit-skin smear demonstrating acid-fast bacilli. The genius of this definition is that it allows diagnosis at the most peripheral health facility without any laboratory beyond a skin smear, and the anaesthetic skin patch alone — confirmed by sensory testing — is enough to begin treatment.

The skin lesions of leprosy vary along the disease spectrum, and learning to read their morphology is the first diagnostic step. At the high-immunity (tuberculoid) end, lesions are few — often a single, well-defined, hypopigmented or erythematous patch or plaque with a dry, hairless, anaesthetic surface and a raised active margin. At the low-immunity (lepromatous) end, lesions are numerous, ill-defined, symmetrically distributed, and infiltrated, producing diffuse thickening of the skin, nodules, loss of eyebrows (madarosis), and in advanced disease the characteristic leonine facies. Sensory loss within lesions follows a sequence: temperature sensation is lost first, then pain, then light touch.

Ridley-Jopling Spectrum of Leprosy

Key points to anchor before moving on:
- The diagnosis requires any one of the three cardinal signs — anaesthetic patch, thickened nerve, or positive smear.
- Sensory loss over a skin lesion is the most specific bedside clue and distinguishes leprosy from common mimics like tinea or vitiligo.
- Nerve thickening can be felt even when the overlying skin looks normal.

Mycobacterium leprae and the Immunological Basis of Disease

Immunological Spectrum of Leprosy

The remarkable clinical diversity of leprosy — from a single trivial-looking patch to widespread disfiguring infiltration — is explained almost entirely by the host's immune response rather than by differences in the organism itself. Mycobacterium leprae is an obligate intracellular acid-fast bacillus with a strong tropism for Schwann cells and skin macrophages, and a preference for cooler tissues that explains why it targets the skin, superficial nerves, the anterior eye, and the testes while sparing warmer internal organs. Because it cannot be grown in artificial culture, the disease is understood and classified largely through the immune-pathological response it provokes.

The organising principle is the strength of cell-mediated immunity (CMI) directed against M. leprae. Where CMI is strong (a vigorous TH1 response with interferon-gamma, macrophage activation, and well-formed epithelioid granulomas), the host contains and kills the bacilli efficiently — producing paucibacillary disease with few lesions, prominent nerve damage from the brisk immune reaction, and a positive lepromin (Mitsuda) skin test. Where CMI is weak or absent (a TH2-skewed response with abundant but ineffective antibody), bacilli multiply unchecked inside foamy macrophages, producing multibacillary disease with numerous lesions, very high bacillary loads, and a negative lepromin test. The continuous gradient between these two immunological poles is exactly what the Ridley-Jopling classification captures.

This immunological framing has two crucial clinical consequences:
- Nerve damage in tuberculoid disease comes from the immune reaction to a few bacilli (intense local inflammation in a nerve), whereas in lepromatous disease it comes from heavy bacillary infiltration of many nerves over time.
- The immunologically unstable borderline parts of the spectrum are the most prone to acute immune-mediated episodes called lepra reactions (covered in a later SDL).

Ridley-Jopling Spectrum — Clinical and Histological Features

Ridley-Jopling Spectrum of Leprosy

The Ridley-Jopling classification is an immunological and histological spectrum that grades a patient's disease according to their cell-mediated immunity against M. leprae. It runs as a continuum through five points — Tuberculoid (TT) → Borderline-Tuberculoid (BT) → Mid-Borderline (BB) → Borderline-Lepromatous (BL) → Lepromatous (LL) — with Indeterminate (I) leprosy standing apart as an early, not-yet-classifiable lesion. The tuberculoid (TT) pole represents high host immunity and a paucibacillary state; the lepromatous (LL) pole represents low or absent immunity and a multibacillary state; the borderline group (BT, BB, BL) is immunologically unstable and sits between them. This is a continuous spectrum precisely because the underlying variable — cell-mediated immunity — is itself continuous.

Moving from the TT pole to the LL pole, the clinical, bacteriological, and histological features change in a predictable, internally consistent way that you should be able to reconstruct from the immunology alone. As immunity falls, the number of lesions rises, lesions become less well-defined and more symmetrical, sensory loss becomes less sharply demarcated, bacillary load (and the slit-skin smear result) rises, the lepromin test turns from strongly positive to negative, and the histology shifts from well-formed epithelioid granulomas with lymphocytes and no bacilli (TT) to sheets of foamy (Virchow) macrophages packed with bacilli and no organised granuloma (LL). Indeterminate leprosy, by contrast, is a single ill-defined hypopigmented macule with minimal sensory change and nonspecific histology — an early lesion that may heal spontaneously or evolve toward one of the determinate types.

Feature	TT (Tuberculoid)	BT	BB (Mid-borderline)	BL	LL (Lepromatous)
Cell-mediated immunity	High	Moderate-high	Intermediate (unstable)	Low	Absent
Number of lesions	Single / very few	Few, asymmetric	Several	Many	Innumerable, symmetric
Lesion definition	Well-defined, dry, anaesthetic	Fairly defined	'Punched-out'/annular	Ill-defined	Diffuse infiltration, nodules
Sensory loss	Marked, early	Present	Present	Less marked	Late, glove-and-stocking
Bacillary load / smear	Negative	Negative or scanty	Moderate	High	Very high (BI 5-6)
Lepromin (Mitsuda) test	Strongly positive	Positive	Negative	Negative	Negative
Histology	Epithelioid granuloma, lymphocytes, no bacilli	Granuloma with some disorganisation	Diffuse epithelioid, no Langhans	Foamy macrophages, many bacilli	Sheets of foamy (Virchow) macrophages, globi

Key points:
- Memorise the order TT → BT → BB → BL → LL as a one-way gradient of falling immunity and rising bacillary load.
- Indeterminate leprosy is NOT a point on this spectrum — it is an early, unclassified lesion.
- BB (mid-borderline) is the most immunologically unstable point and the least stable clinically.